These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1783791)

  • 1. Steroid therapy in recent "quiet nerve paralysis" in pure neuritic leprosy.
    Jaiswal AK; Shetty MK
    Indian J Lepr; 1991; 63(2):223-5. PubMed ID: 1783791
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Arthritis as presenting manifestation of pure neuritic leprosy--a rheumatologist's dilemma.
    Al Attia HM
    Rheumatology (Oxford); 2008 Jan; 47(1):110-1; author reply 111-2. PubMed ID: 18077500
    [No Abstract]   [Full Text] [Related]  

  • 3. Borderline tuberculoid leprosy developing in a pure neuritic case.
    Porichha D; Mahapatra DC
    Indian J Lepr; 1991; 63(2):235-7. PubMed ID: 1783794
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary drug resistance to both rifampicin and dapsone in a paucibacillary leprosy patient.
    Koranne RV; Srivastava G
    Indian J Lepr; 1988 Jan; 60(1):90-2. PubMed ID: 3060548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of rifampin and clofazimine ointments in the treatment of leprosy.
    Venkateswarlu B; Venkataramana D; Rao AV; Prabhakar MC; Reddy BM
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):269-70. PubMed ID: 1522368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Question: Can you identify this condition? Tuberculoid leprosy.
    Kalisiak M; Yeung R; Dytoc M
    Can Fam Physician; 2009 Jan; 55(1):55, 56. PubMed ID: 19155370
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-drug therapy in bacilliferous leprosy--two years experience.
    Kaur S; Sharma VK; Kumar B; Singh M; Kaur I
    Indian J Lepr; 1985; 57(3):483-90. PubMed ID: 3831085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hyperpigmented cutaneous lesions in tuberculoid leprosy.
    Chattopadhyay SP; Gupta CM
    Indian J Lepr; 1988 Jan; 60(1):63-5. PubMed ID: 3204275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid therapy in recent "quiet nerve paralysis" in leprosy. Report of a study of twenty-five patients.
    Srinivasan H; Rao KS; Shanmugam N
    Lepr India; 1982 Jul; 54(3):412-9. PubMed ID: 7176532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD; Tantiongco PR
    Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinicopathological study of multidrug therapy in borderline tuberculoid leprosy.
    Kar PK; Arora PN; Ramasastry CV; Dhaka RS
    J Indian Med Assoc; 1994 Oct; 92(10):336-7. PubMed ID: 7822849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance and multi-drug therapy in leprosy.
    Chatterjee BR
    Indian J Lepr; 1989 Jul; 61(3):328-32. PubMed ID: 2768881
    [No Abstract]   [Full Text] [Related]  

  • 16. Changing picture of leprosy in North Arcot District, Tamil Nadu after M.D.T.
    Ekambaram V; Rao MK
    Indian J Lepr; 1989 Jan; 61(1):31-43. PubMed ID: 2784822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
    Li WZ
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
    [No Abstract]   [Full Text] [Related]  

  • 18. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ominous sign of a disfiguring disease. Leprosy (Hansen's disease).
    Winter CA; Hsu S
    Postgrad Med; 2000 May; 107(5):87-9. PubMed ID: 10844944
    [No Abstract]   [Full Text] [Related]  

  • 20. Dapsone syndrome: an incomplete form.
    Jaswal R; Thami GP; Kanwar AJ
    Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.